Licensee Pipeline
Dyax provides access to its phage display libraries in various types of licenses and collaborations under the Licensing and Funded Research Program (LFRP).
Under the LFRP, we maintain more than 70 licenses and collaborations with various research, biotechnology and pharmaceutical companies. These licensees have advanced into clinical development numerous drug candidates identified using our phage display libraries.
Our licensee pipeline currently consists of 17 clinical-stage drug candidates.
| Phase 1 | Phase 2 | Phase 3 | Market | ||
|---|---|---|---|---|---|
|
Antibody Peptide Not identified
|
|||||
|
|
|||||
| Eli Lilly/ImClone | |||||
| IMC-1121B (VEGFR-2/KDR) | |||||
| IMC-11F8 (EGFR) | |||||
| IMC-A12 (IGF-1R) | |||||
| IMC-3C5 (VEGFR-3) | |||||
| Amgen | |||||
| AMG 479 (IGF-1R) |
|||||
| AMG 386 (Ang-1/Ang-2) |
|||||
| AMG 780 (Ang-2) |
|||||
| Alexion | |||||
| ALXN6000 (CD-200) |
|||||
| Biogen Idec | |||||
| BIIB 033 (LINGO-1) |
|||||
| Genentech/BioInvent | |||||
| BI-204 (APOB-100) |
|||||
| Merrimack/sanofi-aventis | |||||
| MM-121 (ErbB3) |
|||||
| Micromet/Merk Serono |
|||||
| MT201 (EpCAM) | |||||
| BioInvent | |||||
| BI-505 (ICAM-1) |
|||||
| Company Confidential | |||||
| 1 compound | |||||
| 3 compounds | |||||